Tag Archives: intensive statin therapy

This drive towards generic prescribing for statins for all patients, with reduced efficacy, is against the published data from a large series of randomised-controlled trials and is counterintuitive. Funding organisations are being misinformed if they consider the swapping of effective treatment in this high-risk population is at all benign. This review seeks to demonstrate the strength of data and real-world experience suggesting that intensive statin therapies have real benefits for high-risk patients.  Introduction Dr Rob Butler There has been mounting controversy within a number of healthcare systems due to the expanding indications for s